CIK 0001668397 · Large accelerated filer
Medpace Holdings, Inc.
Sign in to watch- Ticker
- MEDP
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 320434904
- Phone
- (513) 579-9911
- Business address
- 5375 MEDPACE WAY, CINCINNATI, OH, 45227
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $191,774,429
- in 16 filings
Net −$191,774,429. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-25 | Troendle August J. President & CEO | Sale | −154 | $620.60 | $96K | 389,302 |
| 2026-09-24 | Troendle August J. President & CEO | Sale | −27,833 | $621.33 | $17.3M | 389,456 |
| 2026-09-23 | Troendle August J. President & CEO | Sale | −16,083 | $628.64 | $10.1M | 417,289 |
| 2026-09-22 | Troendle August J. President & CEO | Sale | −49,018 | $628.11 | $30.8M | 433,372 |
| 2026-09-21 | Troendle August J. President & CEO | Sale | −21,883 | $623.29 | $13.6M | 482,390 |
| 2026-09-17 | Troendle August J. President & CEO | Sale | −10,880 | $620.40 | $6.7M | 504,273 |
| 2026-09-16 | Troendle August J. President & CEO | Sale | −8,770 | $621.29 | $5.4M | 515,153 |
| 2026-09-15 | BURWIG SUSAN E Exec. VP, Operations | Option exercise | +3,000 | $166.73 | $500K | 65,984 |
| 2026-09-15 | BURWIG SUSAN E Exec. VP, Operations | Option exercise · Employee Stock Option (Right to Buy) | −3,000 | 8,028 | ||
| 2026-09-15 | Troendle August J. President & CEO | Sale | −15,971 | $620.84 | $9.9M | 523,923 |
| 2026-08-27 | Troendle August J. President & CEO | Sale | −650 | $620.27 | $403K | 539,894 |
| 2026-08-26 | Kraft Robert O. Director | Option exercise | +3,858 | $84.36 | $325K | 4,813 |
| 2026-08-26 | Kraft Robert O. Director | Sale | −3,858 | $617.81 | $2.4M | 955 |
| 2026-08-26 | Kraft Robert O. Director | Option exercise · Stock Option (Right to Buy) | −3,858 | 0 | ||
| 2026-08-26 | Troendle August J. President & CEO | Sale | −4,000 | $620.03 | $2.5M | 540,544 |
| 2026-08-25 | Troendle August J. President & CEO | Sale | −673 | $620.38 | $418K | 544,544 |
| 2026-08-24 | Troendle August J. President & CEO | Sale | −1,983 | $620.23 | $1.2M | 545,217 |
| 2026-08-21 | Troendle August J. President & CEO | Sale | −13,995 | $624.45 | $8.7M | 547,200 |
| 2026-08-20 | Brady Kevin M. CFO & Treasurer | Option exercise | +3,400 | $138.87 | $472K | 16,230 |
| 2026-08-20 | Brady Kevin M. CFO & Treasurer | Sale | −3,400 | $625.24 | $2.1M | 12,830 |
Page 2 of 10 · 196 trades